TABLE 3.
Sample | Viral target | Discordance | Specimen type |
Same specimen analyzed? | Difference in sample collection times (h) | |
---|---|---|---|---|---|---|
BFPP | SOC | |||||
1 | Coronavirus | SOC RP2+, BFPP− | BAL | BAL | No | 34:35 |
2 | Coronavirus | SOC RP2+, BFPP− | BAL | BAL | Yes | NA |
3 | Adenovirus | SOC RP2+, BFPP− | Tracheal aspirate | Tracheal Aspirate | Yes | NA |
4 | Influenza A virusb | SOC RP2+, BFPP− | Tracheal aspirate | Tracheal aspirate | Yes | NA |
5 | Influenza A virus | BFPP+, SOC RP2− | BAL | BAL | Yes | NA |
6 | Coronavirus | BFPP+, SOC RP2− | Sputum | BAL | No | 9:25 |
7 | Parainfluenza virus | BFPP+, SOC RP2− | Tracheal aspirate | Tracheal aspirate | Yes | NA |
The Biofire respiratory panel V2.0 (RP2) was performed for each of the lower respiratory tract (LRT) samples included as a laboratory-developed test.
Specimen retrospectively positive for influenza A virus by Xpert Flu/RSV Xpress assay (cycle threshold [CT], 34.8).